Katsari, Marina
Kasselimis, Dimitrios S. http://orcid.org/0000-0001-6324-0384
Giogkaraki, Erasmia
Breza, Marianthi
Evangelopoulos, Maria-Eleftheria
Anagnostouli, Maria
Andreadou, Elisabeth
Kilidireas, Costas
Hotary, Alia
Zalonis, Ioannis
Koutsis, Georgios
Potagas, Constantin
Funding for this research was provided by:
State Scholarships Foundation (MIS-5000432)
Article History
Received: 13 October 2019
Revised: 15 January 2020
Accepted: 20 January 2020
First Online: 1 February 2020
Compliance with ethical standards
:
: The authors report no conflicts of interest.
: Dr Koutsis has received research grants from Teva and Genesis Pharma and provided consultation services for and received honoraria from Novartis, Genzyme, Genesis Pharma, Specifar, Pfizer, and Teva. Dr Breza reports no disclosures. Dr Zalonis reports no disclosures. Dr Potagas reports no disclosures. Dr Evangelopoulos has provided consultation services for and received honoraria from Novartis, Biogen, and Teva. Dr Anagnostouli has received research grants from Biogen, Merck- Serono, Novartis, Teva, Bayer, and Genzyme, as well as lecture-fees from Novartis, Teva, Biogen and Genzyme. Dr Andreadou has received research grants from Biogen, Merck-Serono, Novartis, and Sanofi-Aventis, as well as lecture-fees from Teva. Dr Kilidireas has received research grants from Biogen, Novartis, Teva, and Merck-Serono. Dr Kasselimis is supported by IKY Scholarships Programme co-financed by the European Union (European Social Fund [ESF]) and Greek national funds through the action entitled “Reinforcement of Postdoctoral Researchers,” in the framework of the Operational Programme “Human Resources Development Program, Education and Lifelong Learning” of the National Strategic Reference Framework (NSRF) 2014–2020.
: The study was approved by the Eginition hospital ethics committee.